Company
We’re Horizon Therapeutics, a global biotechnology company driven by a simple idea: We believe that science and compassion must work together to transform lives.
Pipeline
Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients.
Medicines
We’re driven by a clear purpose: to improve patients’ lives. And the clearest expression of that purpose is the portfolio of medicines we offer to treat rare, autoimmune and severe inflammatory diseases.
News
06/06/2023
Horizon Therapeutics plc announces premium partnership with KPMG Women’s Irish Open
06/05/2023
Horizon Therapeutics plc Announces Data from the TEPEZZA® (teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low CAS Thyroid Eye Disease (TED) to be Presented at the Upcoming Endocrine Society (ENDO) Annual Meeting